 LEXINGTON, Mass.--BUSINESS WIRE--Frequency Therapeutics, Inc. Nasdaq: FREQ, a clinical-stage biotechnology company focused on harnessing the bodys innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced that Chief Executive Officer David L. Lucchino will present at the following investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference: On-demand viewing will start Monday, September 13, 2021 at 7:00 a.m. ET Oppenheim 